baber/WOPTO huggingface dataset:
Patent AU-2002331244-B2 (AU)
Title: Methods and compounds for the targeting of protein to exosomes
Inventor: DELCAYRE ALAIN
IPC: G01N33/50
Filed: 2002-08-14
Granted: 2007-02-15
Abstract: The present invention relates to compositions and methods for selectively expressing a polypeptide in a membrane vesicle. The invention also relates to genetic constructs and recombinant cells suitable to produce such membrane vesicles. This invention also relates to such functionalized membrane vesicles as well as to methods of making antibodies, methods of producing or regulating an immune response as well as to methods of screening or identifying binding partners using the same. The invention more particularly uses lactadherin or portions thereof to selectively express polypeptides in membrane vesicles, of natural or synthetic origin. This invention can be used in experimental, research, therapeutic, prophylactic or diagnostic areas.
Patent AU-2002332750-B2 (AU)
Title: Heat pack with expansion capability
Inventor: PITZ KEVIN J
IPC: F24V30/00
Filed: 2002-08-29
Granted: 2008-05-15
Abstract: A disposable heating device is disclosed that includes a container having a first zone, a second zone and a third zone. A fuel is contained within the first zone and an oxidizing agent contained within the second zone. A first frangible separator disposed between the first zone and the second zone. The first frangible separator is manually operable to provide communication between the first zone and the second zone thereby defining a reaction zone. A second frangible separator is responsive to an exothermic chemical reaction within the reaction chamber. The second frangible separator is operable to provide communication between the reaction chamber and the third zone. Communication between the first zone and the second zone allows mixing of the fuel and the oxidizing agent to initiate an exothermic chemical reaction and an environmental parameter associated with the exothermic chemical reaction operates the second frangible separator.
Patent AU-2002356913-B2 (AU)
Title: Reagent-less whole-blood glucose meter
Inventor: CORTELLA JULIAN M
IPC: A61B5/145
Filed: 2002-11-06
Granted: 2006-09-28
Abstract: A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.
Patent AU-2003200990-B2 (AU)
Title: Process and device for preparing a melt of an alloy for a casting process
Inventor: STERLING EVGENIJ
IPC: C22B9/20
Filed: 2003-03-12
Granted: 2008-05-22
Abstract: Production of a melt of an alloy for casting comprises:  (a) placing the melt having a temperature lying above the liquidus temperature of the alloy in a crystallization vessel (14) heated to a temperature lying below the liquidus temperature;  (b) adding an alloy as a powder; and  (c) mixing the melt and powder using electrical and/or magnetic forces.  An Independent claim is also included for a device for carrying out the process.  Preferred Features: The melt is introduced into the crystallization vessel as a beam extending between two electrodes (17, 23) to which an electrical voltage is applied. A magnetic field is formed in the crystallization vessel. The melt is suctioned into the vessel under pressure and with the introduction of a protective gas.
Patent AU-2003218267-B2 (AU)
Title: (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
Inventor: GRZYWACZ PAWEL K
IPC: A61P17/16
Filed: 2003-03-20
Granted: 2007-12-20
Abstract: This invention discloses (20S)-1alpha-hydroxy-2alpha-methyl-19-nor-vitamin D<SUB>3 </SUB>and (20S)-1alpha-hydroxy-2beta-methyl-19-nor-vitamin D<SUB>3 </SUB>and pharmaceutical uses therefor. These compounds exhibit pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. These compounds also have very significant calcemic activity and therefore may be used to treat immune disorders in humans as well as metabolic bone diseases such as osteoporosis.
Patent AU-2003233902-B2 (AU)
Title: Device for showing tensile stress
Inventor: MAMIE ANDRE
IPC: G01L5/06
Filed: 2003-06-13
Granted: 2008-11-13
Abstract: In this device for indicating ( 10 ) pretensioning forces in a tensioning element ( 7 ), such as tie-down straps or tie-down ropes, the spring surrounds the tie bolt ( 3 ) which is located on the loop of the tie-down strap, and in response to weak forces describes a path ( 6 ) which is easily visible. The combination of two components which differ in shape allows the spring ( 1 ) to maintain its shape and spring constant. As a result, the pretensioning force is indicated directly, yet the spring is not subject to an additional load under high tensions but is protected by positive engagement.
Patent AU-2003262473-B2 (AU)
Title: Methods and systems for authentication of a user for sub-locations of a network location
Inventor: PEARO CHRIS
IPC: G06F21/31
Filed: 2003-11-24
Granted: 2009-05-28
Abstract: Methods and systems authenticate a user of a sub-location of a network location by using a first cookie for authentication within the network location, such as a domain of the world wide web, and also use a second cookie for authentication within a sub-location of the network location. When the user attempts to visit a network location or sub-location within the network location, the server of the network location authenticates the user by obtaining a previously stored cookie from the user's computer and validating it for the network location. Upon being authenticated by the validation, a cookie for a sub-location within the network location is generated for the user and provided to the user's computer. When the user attempts to access the sub-location within the network location, the cookie provided to the user's computer for the sub-location is obtained and validated to authenticate the user for the sub-location.
Patent AU-2003285410-B2 (AU)
Title: Membrane for tangential filtration and production method thereof
Inventor: LESCOCHE PHILIPPE
IPC: B01D63/06
Filed: 2003-10-20
Granted: 2008-09-25
Abstract: Membrane for the tangential filtration of a fluid, said membrane comprising a porous support ( 2 ) delimiting at least one flow channel ( 3 ) for the fluid flowing in a given direction (f) between an inlet ( 6 ) and an outlet ( 7 ), the inner surface ( 4 ) of the porous support ( 2 ) which delimits channel ( 3 ) being coated with at least one separator layer ( 5 ) for the fluid, characterized in that the support has variable partial pore-filling (c) extending from the inner surface ( 4 ) of support ( 2 ) on which the separator layer ( 5 ) is deposited, said variable partial pore-filling creating a mean porosity gradient on portion ( 8 ) of support ( 2 ) of given constant thickness (e) extending from the inner surface ( 4 ) of support ( 2 ), the minimum mean porosity being located at the inlet ( 6 ) and the maximum mean porosity at the outlet ( 7 ).
Patent AU-2004234001-B2 (AU)
Title: Medical device with antimicrobial layer
Inventor: VIRAG ROBERT
IPC: A61F2/04
Filed: 2004-04-29
Granted: 2010-08-12
Abstract: A medical device includes a conduit for a fluid. The conduit has a wall formed of a hydrophobic polymer with a hydrophilic polymer layer extruded over it, and an antimicrobial substantially dispersed within the hydrophilic polymer. The antimicrobial compound may be a predetermined amount of phosphorus-based glass having a predetermined quantity of a metal such as silver substantially dispersed therein. The medical device may be an endotracheal tube made by providing a hydrophobic polymer, a hydrophilic polymer and an antimicrobial compound, forming the hydrophobic polymer, the hydrophilic polymer and the antimicrobial compound into a conduit, and forming a cuff on an end of the conduit.
Patent AU-2004244755-B2 (AU)
Title: Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds
Inventor: SEIFERT WENKE
IPC: A61K33/243
Filed: 2004-06-11
Granted: 2009-06-25
Abstract: The invention concerns combined pharmaceutical preparations which inhibit abnormal growth of tumor cells. The combined preparations comprise as active substances compounds having glutaminase activity in combination with certain antineoplastic agents. The invention concerns in particular combined preparations of compounds having glutaminase activity and cytostatic compounds.
Patent AU-2004280288-B2 (AU)
Title: Antibody compositions and methods
Inventor: JONES PHILIP
IPC: C12N15/13
Filed: 2004-10-08
Granted: 2007-02-01
Abstract: Disclosed is a PEG-linked polypeptide comprising an antibody single variable domain, wherein the variable domain comprises a framework region and has an antigen binding site, and said variable domain binds antigen as a single antibody variable domain in the polypeptide, and further wherein said PEG is present as one or more molecules linked to the polypeptide at a cysteine or lysine residue in the framework regions of said antibody single variable domain.
Patent AU-2004303511-B2 (AU)
Title: Paper comprising quaternary nitrogen containing cellulose ether
Inventor: HORST PETER MARTEN VAN DER
IPC: D21H19/24
Filed: 2004-12-21
Granted: 2009-09-24
Abstract: The invention relates to paper comprising a filler and a cellulose ether wherein the cellulose ether comprises a quaternary ammonium group, with the proviso that the cellulose ether is not a hydroxyethyl cellulose.
Patent AU-2004324762-B2 (AU)
Title: Method and system for detecting attempts at malicious action against an installation under surveillance
Inventor: TONELLI GIORGIO
IPC: G08B13/12
Filed: 2004-11-12
Granted: 2009-07-23
Abstract: Described are embodiments that detect attempts at malicious action against an installation under surveillance based on signals detected by a plurality of sensors distributed near an installation.
Patent AU-2005200178-B2 (AU)
Title: Profiled rail system for bridging floorcovering transitions
Inventor: SONDERMANN FRANK
IPC: E04F11/16
Filed: 2005-01-14
Granted: 2007-02-15
Abstract: The cover profile (3) has two webs (11) which point downwards and have partly cylindrical internal contours (12) so that they can combine to form an outer shell for a rotary joint (10) between the cover profile and a base profile (2). The internal contours have a shape adapted to that of the inner shell (9) for the rotary joint and allow the cover profile to be adjusted in a stepwise manner. The system comprises a base profile with at least one vertical arm (6), the latter being provided with the inner shell for the rotary joint. The cover profile is pivotally supported by the inner shell.
Patent AU-2005247154-B2 (AU)
Title: Injection device
Inventor: BARROW-WILLIAMS TIM
IPC: A61M5/20
Filed: 2005-05-27
Granted: 2010-07-15
Abstract: An injection device (210) is described. A housing (212) receives a syringe and includes a return spring (226) for biasing the syringe from an extended position in which its needle (218) extends from the housing (212) to a retracted position in which the it does not. A drive spring (230) acts on a first drive element (232) and a second drive element (234) acts upon the syringe to advance it from its retracted position to its extended position and discharge its contents through the needle. The first drive element (232) is capable of movement relative to the second (234) once a nominal decoupling position has been reached. A release mechanism is activated when the first drive element (234) is further advanced to a nominal release position, to release the syringe (214) from the action of the drive spring (230), whereupon the return spring (226) restores the syringe (214) to its retracted position. A locking mechanism (337, 375) confines the returned syringe in its retracted position.
Patent AU-2005321346-B2 (AU)
Title: Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
Inventor: ELIE LEVERD
IPC: A61K9/16
Filed: 2005-12-20
Granted: 2011-06-23
Abstract: This invention relates to solid and stable dispersions of a hydrosoluble derivative of vinca alkaloids in at least one polyethyleneglycol with a molecular mass between 800 and 30 000.
Patent AU-2006227572-B2 (AU)
Title: Enzymatic demethylation of flavonoids
Inventor: VERSTRAETE WILLY
IPC: C12P17/02
Filed: 2006-03-27
Granted: 2011-03-17
Abstract: The invention discloses the demethylation of 5-methoxyflavonoids by bacterial enzymes, the use of these enzymes in the production of phytoestrogens in vitro, and in pharmaceutical compositions in combination with a source of methylated 5-methoxyprenylflavonoids.
Patent AU-2006258841-B2 (AU)
Title: Oxyntomodulin analogues and their effects on feeding behaviour
Inventor: GHATEI MOHAMMAD ALI
IPC: A61K38/26
Filed: 2006-06-13
Granted: 2012-05-03
Abstract: Compounds of the invention are novel peptide analogues of oxyntomodulin (oxm) in which one or more amino acids of the oxm sequence have been changed. Changing amino acids 15 - 24 of oxm to either amino acids 968 - 977 of the α-latrotoxin peptide (and variations thereof) or amino acids 15 -24 of exendin-4 (and variations thereof), or combinations of sequences from these sources, and/or changing amino acids 27 - 33 of oxm to amino acids 27 - 33 of exendin-4, and/or the addition of amino acids to the C-terminus of the peptide, results in a series of analogues of oxm that demonstrate the oxm like activity of reducing food intake, and with certain embodiments a greater ability to decrease food intake.
Patent AU-2006271682-B2 (AU)
Title: Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
Inventor: JORAND-LEBRUN CATHERINE
IPC: A61P29/00
Filed: 2006-07-14
Granted: 2012-07-05
Abstract: The present invention is related to the use of a Glepp-1 inhibitor for the manufacture of a medicament for the treatment of an autoimmune and/or an inflammatory disorder.
Patent AU-2006294835-B2 (AU)
Title: N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
Inventor: MUSSELMAN JEFFREY D
IPC: C07D239/90
Filed: 2006-09-22
Granted: 2011-05-26
Abstract: The invention relates to substituted N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamid derivatives which modulate androgen receptors to treat conditions such as: osteoporosis, peridontal disease, bone fracture, frailty, and sarcopenia.
Patent AU-2006314404-B2 (AU)
Title: Method for decomposing metal sulphate
Inventor: METSARINTA MAIJA-LEENA
IPC: C01B13/32
Filed: 2006-11-10
Granted: 2012-04-19
Abstract: The method of the invention relates to the decomposition in a fluidized bed of metal sulphates generated in the metallurgical industry. The decomposition of metal sulphates is carried out so that the metal oxides generated are recovered in such a pure form that they can be recycled to be reused in the manufacture of metal alloys such as steel. In particular, sulphates containing nickel, iron and chrome are decomposed in oxidising conditions using pyrites or pyrrhotite as the fuel and bed material.
Patent AU-2006326852-B2 (AU)
Title: A liquid dispensing applicator with flexible valve member
Inventor: WITHOOS ROBERT
IPC: B65D37/00
Filed: 2006-12-22
Granted: 2012-09-20
Abstract: The invention concerns a liquid dispensing applicator for a volatile liquid. The liquid dispensing applicator includes a cap member for attachment to a hollow bodied container having a reservoir for retaining a liquid. The cap member comprises a sleeve to receive and conduit liquid contained within the reservoir. The applicator further includes a valve member and a dispensing member co-operating with at least the first end of the shaft. The valve member is retained within the sleeve of the cap comprising a substantially flexible shaft having a first end projecting from said sleeve exterior. The valve member is flexibly operable against a bias at said first end to move from a first substantially closed position to a second open position to allow displacement of a quantity of liquid from within the sleeve, onto the dispensing member, for subsequent application.
Patent AU-2006333484-B2 (AU)
Title: Flexible package with opening feature
Inventor: CLARK JR JAMES J
IPC: B65D83/08
Filed: 2006-10-26
Granted: 2012-05-03
Abstract: A flexible package has a top surface (20), a bottom surface (22) and at least one side wall (16) together defining an interior volume of the package. An opening device (5) is attached to the top surface and is at least in part detachable from the top surface to provide access to the interior volume. An article (26) is secured to the opening device for conjoint movement with the opening device upon detachment of the opening device from the top surface of the package. In another embodiment, a portion of the side wall extends outward beyond the top surface to a free edge. A closure system is operable on the extended portion of the side wall to permit selective closing and opening of the package.
Patent AU-2007210090-B2 (AU)
Title: Method of treating chronic kidney disease
Inventor: TOWN WINSTON
IPC: A01N55/02
Filed: 2007-01-26
Granted: 2013-08-22
Abstract: The present invention discloses pharmaceutical-grade ferric organic compounds having enhanced dissolution rate. These ferric organic compounds, including but are not limited to ferric citrate, are useful for treating chronic kidney disease.
Patent AU-2007223933-B2 (AU)
Title: Wastewater treatment system and method
Inventor: TODD WINGERS
IPC: C02F3/00
Filed: 2007-03-08
Granted: 2011-09-08
Abstract: The invention is directed to a method and apparatus for treating wastewater. The wastewater treatment system includes a bioreactor (120) including activated carbon and a first biological population. The wastewater treatment system may also include a membrane bioreactor (140) and/or a wet oxidation unit (150).
Patent AU-2007257926-B2 (AU)
Title: Stability testing in reservoir simulation flash calculations
Inventor: SAAF FREDRIK E
IPC: G06G7/48
Filed: 2007-06-05
Granted: 2012-05-31
Abstract: Methods and computer readable media for performing a compositional reservoir simulation of a subterranean hydrocarbon-bearing reservoir is provided. Reduced variables for flash computations are utilized with a methodology of conditional stability testing for achieving optimal efficiency of phase behavior computations in a compositional reservoir simulator. A least abundant phase is selected as primary variables for a primary phase and a secondary phase is selected for a more abundant phase to ensure stability by not dividing by a value near zero due to the selection of the primary phase as being associated with phase which is the least abundant. A bounded interval may be used to limit solution changes in reduced variable algorithms to achieve greater stability of algorithms. Stability tests may be performed during flash computations using reduced variables by employing a direct residual form based on the definition of the reduced variables and the tangent-plane distance condition.
Patent AU-2007283204-B2 (AU)
Title: A device for dispersing a gas into a liquid
Inventor: RAINER IMHOF
IPC: B01F3/04
Filed: 2007-08-13
Granted: 2011-11-10
Abstract: An aeration cartridge (10) within an outer vessel, the aeration cartridge (10) comprising a tube (18) constructed from two or more longitudinally joined cylindrical sections (20), wherein respective ends of the cylindrical sections (20) are shaped so that when they are joined together, at least one slot (24) passing from an inner surface of the tube (18) to an outer surface of the tube (18) is created at the join, and wherein the outer vessel is capable of being connected to a high pressure gas supply.
Patent AU-2007358105-B2 (AU)
Title: An electronic point of sales vending control apparatus
Inventor: KENNA SEAN
IPC: G06F13/00
Filed: 2007-08-28
Granted: 2013-05-16
Abstract: An electronic point of sales (EPOS) vending control apparatus for connecting different types of electronic point of sales (EPOS) systems with different types of vending machines is disclosed. The apparatus provides means for ensuring that the signals carrying control instructions for each EPOS system and vending machine connected to the control apparatus are in an appropriate format. The invention also ensures that one person is fully accountable for all vends originating from a particular EPOS system to provide one point of access and includes a verifiable audit trail. Each vend operation is recorded against a single authenticated operator.
Patent AU-2008201674-B2 (AU)
Title: Furrow Opener
Inventor: BARTON PETER HUGH
IPC: A01B15/16
Filed: 2008-04-16
Granted: 2012-11-08
Abstract: A furrow opener device includes a disc arranged to open a primary furrow in the ground. A 5 scraper body has a leading scraper edge supported alongside the disc to scrape the disc. A wing member is supported on a bottom portion of the scraper body in proximity to a bottom end of the disc and extends laterally outwardly away from the disc so as to be arranged to open a groove in the primary furrow projecting laterally to one side of the primary furrow, and a tube extends generally downward to an output opening located adjacent the wing member and 10 is arranged for depositing product into the groove. * 0 88 46 -86
Patent AU-2008208869-B2 (AU)
Title: Method for producing glucose by enzymatic hydrolysis of cellulose that can be pretreated with an ionic liquid containing a polyatomic anion
Inventor: D ANDOLA GIOVANNI
IPC: C12P19/02
Filed: 2008-01-22
Granted: 2014-02-13
Abstract: The invention relates to a method for producing glucose from cellulose material, in which a starting material containing cellulose is treated with a liquid treatment medium that comprises an ionic liquid, anions are selected therefrom using polyatomic anions, and the material containing cellulose and which is treated with ionic liquid undergoes enzymatic hydrolysis.
Patent AU-2008214036-B2 (AU)
Title: Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (DC- ASGPR)
Inventor: ZURAWSKI SANDRA
IPC: C12P21/08
Filed: 2008-02-02
Granted: 2012-11-01
Abstract: The present invention includes compositions and methods for making and using anti DC- ASGPR antibodies that can, e.g., activate DCs and other cells.
Patent AU-2008229176-B2 (AU)
Title: Centralized licensing services
Inventor: KINSLEY MICHAEL
IPC: G07F17/32
Filed: 2008-02-28
Granted: 2013-01-31
Abstract: Methods and devices are provided for central management of licenses, particularly those relating to wagering games. A license proxy deployed in and/or dedicated to a gaming establishment may operate under the control of a central licensing manager controlled by another entity, e.g., by a game provider. The license proxy may receive requests to enable features of an electronic gaming machine of the gaming establishment (e.g., game themes, player tracking features and/or peripheral device features) and determine, based on information provided by the central licensing manager, whether to grant such requests. The license proxy may also process requests to enable features of other devices in a gaming establishment, such as server-based features.